-
1
-
-
33847020437
-
Drug-induced acute angle closure glaucoma
-
Lachkar Y, Bouassida W. Drug-induced acute angle closure glaucoma. Curr Opin Ophthalmol. 2007;18(2):129-133.
-
(2007)
Curr Opin Ophthalmol
, vol.18
, Issue.2
, pp. 129-133
-
-
Lachkar, Y.1
Bouassida, W.2
-
2
-
-
0020622931
-
Posterior subcapsular cataracts, associated with long-term corticosteroid therapy. Prednisolone versus 6α-fluor-16α-methyl-1- dehydrocorticosterone
-
Miltenyi M, Homoki J, Fazekas AK, et al. Posterior subcapsular cataracts, associated with long-term corticosteroid therapy. Prednisolone versus 6 alpha-fluor-16 alpha-methyl-1-dehydrocorticosterone. Helv Paediatr Acta. 1983;38(2):141-147. (Pubitemid 13102880)
-
(1983)
Helvetica Paediatrica Acta
, vol.38
, Issue.2
, pp. 141-147
-
-
Miltenyi, M.1
Homoki, J.2
Fazekas, A.K.3
-
3
-
-
38549111894
-
Drug-induced ocular disorders
-
Li J, Tripathi RC, Tripathi BJ. Drug-induced ocular disorders. Drug Saf. 2008;31(2):127-141. (Pubitemid 351158524)
-
(2008)
Drug Safety
, vol.31
, Issue.2
, pp. 127-141
-
-
Li, J.1
Tripathi, R.C.2
Tripathi, B.J.3
-
5
-
-
0027524493
-
Clinically important ocular reactions to systemic drug therapy
-
Rennie IG. Clinically important ocular reactions to systemic drug therapy. Drug Saf. 1993;9(3):196-211. (Pubitemid 23283912)
-
(1993)
Drug Safety
, vol.9
, Issue.3
, pp. 196-211
-
-
Rennie, I.G.1
-
6
-
-
1242338768
-
Oculogyric crisis in patients taking cetirizine
-
DOI 10.1016/S0002-9394(03)00869-9
-
Fraunfelder FW, Fraunfelder FT. Oculogyric crisis in patients taking cetirizine. Am J Ophthalmol. 2004;137(2):355-357. (Pubitemid 38221016)
-
(2004)
American Journal of Ophthalmology
, vol.137
, Issue.2
, pp. 355-357
-
-
Fraunfelder, F.W.1
Fraunfelder, F.T.2
-
8
-
-
60749092605
-
Cetirizine-induced dystonic reaction in a 6-year-old boy
-
Esen I, Demirpence S, Yis U, et al. Cetirizine-induced dystonic reaction in a 6-year-old boy. Pediatr Emerg Care. 2008;24(9):627-628.
-
(2008)
Pediatr Emerg Care
, vol.24
, Issue.9
, pp. 627-628
-
-
Esen, I.1
Demirpence, S.2
Yis, U.3
-
9
-
-
84855465176
-
Critical care therapeuticsVcefepime-induced neurotoxicity: A review of the evidence
-
Wesley RZ. Critical care therapeuticsVcefepime-induced neurotoxicity: a review of the evidence. Hosp Pharm. 2009;44:557-561.
-
(2009)
Hosp Pharm
, vol.44
, pp. 557-561
-
-
Wesley, R.Z.1
-
10
-
-
52649138483
-
Renal failure is a risk factor for cefepime-induced encephalopathy
-
Garces EO, Andrade de Anzambuja MF, da Silva D, et al. Renal failure is a risk factor for cefepime-induced encephalopathy. J Nephrol. 2008;21(4):526-534.
-
(2008)
J Nephrol
, vol.21
, Issue.4
, pp. 526-534
-
-
Garces, E.O.1
Andrade De Anzambuja, M.F.2
Da Silva, D.3
-
11
-
-
33845299508
-
A case of metoclopramide-induced oculogyric crisis in a 16-year-old girl with cystic fibrosis
-
DOI 10.1097/01.smj.0000232971.27692.0f, PII 0000761120061100000027
-
Lou E, Abou-Zeid N. A case of metoclopramide-induced oculogyric crisis in a 16-year-old girl with cystic fibrosis. South Med J. 2006;99(11):1290-1291. (Pubitemid 44875858)
-
(2006)
Southern Medical Journal
, vol.99
, Issue.11
, pp. 1290-1291
-
-
Lou, E.1
Abou-Zeid, N.2
-
12
-
-
28144455332
-
Diagnosis and management of acute movement disorders
-
DOI 10.1007/s00415-005-0006-x
-
Dressler D, Benecke R. Diagnosis and management of acute movement disorders. J Neurol. 2005;252(11):1299-1306. (Pubitemid 41699017)
-
(2005)
Journal of Neurology
, vol.252
, Issue.11
, pp. 1299-1306
-
-
Dressler, D.1
Benecke, R.2
-
13
-
-
0027034521
-
Ocular side effects of selected systemic drugs
-
Jaanus SD. Ocular side effects of selected systemic drugs. Optom Clin. 1992;2(4):73-96.
-
(1992)
Optom Clin
, vol.2
, Issue.4
, pp. 73-96
-
-
Jaanus, S.D.1
-
14
-
-
21844470270
-
Ocular complications of neurological therapy
-
DOI 10.1111/j.1468-1331.2005.01025.x
-
Hadjikoutis S, Morgan JE, Wild JM, et al. Ocular complications of neurological therapy. Eur J Neurol. 2005;12(7):499-507. (Pubitemid 40956805)
-
(2005)
European Journal of Neurology
, vol.12
, Issue.7
, pp. 499-507
-
-
Hadjikoutis, S.1
Morgan, J.E.2
Wild, J.M.3
Smith, P.E.M.4
-
15
-
-
77958021683
-
Tardive oculogyric crisis associated with amisulpride monotherapy
-
Mendhekar DN, Lohia D, Kataria P. Tardive oculogyric crisis associated with amisulpride monotherapy. J Postgrad Med. 2010; 56(4):305-306.
-
(2010)
J Postgrad Med
, vol.56
, Issue.4
, pp. 305-306
-
-
Mendhekar, D.N.1
Lohia, D.2
Kataria, P.3
-
16
-
-
67651149809
-
Recurrent acute dystonic reaction and oculogyric crisis despite withdrawal of dopamine receptor blocking drugs
-
Schneider SA, Udani V, Sankhla CS, et al. Recurrent acute dystonic reaction and oculogyric crisis despite withdrawal of dopamine receptor blocking drugs. Mov Disord. 2009;24(8):1226-1229.
-
(2009)
Mov Disord
, vol.24
, Issue.8
, pp. 1226-1229
-
-
Schneider, S.A.1
Udani, V.2
Sankhla, C.S.3
-
17
-
-
0018176070
-
Disturbances of ocular movements and blinking in schizophrenia
-
Stevens JR. Disturbances of ocular movements and blinking in schizophrenia. J Neurol Neurosurg Psychiatry. 1978;41(11): 1024-1030. (Pubitemid 9010102)
-
(1978)
Journal of Neurology Neurosurgery and Psychiatry
, vol.41
, Issue.11
, pp. 1024-1030
-
-
Stevens, J.R.1
-
18
-
-
0035046112
-
Cefixime in urinary tract infections with special reference to pediatrics: Overview
-
Fanos V, Cataldi L. Cefixime in urinary tract infections with special reference to pediatrics: overview. J Chemother. 2001;13(2): 112-117. (Pubitemid 32337018)
-
(2001)
Journal of Chemotherapy
, vol.13
, Issue.2
, pp. 112-117
-
-
Fanos, V.1
Cataldi, L.2
-
19
-
-
0024967427
-
Pharmacokinetic properties of cefixime
-
Barre J. Pharmacokinetic properties of cefixime. Presse Med. 1989; 18(32):1578-1582.
-
(1989)
Presse Med
, vol.18
, Issue.32
, pp. 1578-1582
-
-
Barre, J.1
-
20
-
-
0027746014
-
A review of the safety profile of cefixime
-
Wu DH. A review of the safety profile of cefixime. Clin Ther. 1993; 15(6):1108-1119. (Pubitemid 24045913)
-
(1993)
Clinical Therapeutics
, vol.15
, Issue.6
, pp. 1108-1119
-
-
Wu, D.H.1
-
21
-
-
0038642670
-
A receptor blockade in convulsions induced by cephalosporins
-
DOI 10.1016/S0028-3908(03)00188-6
-
Sugimoto M, Uchida I, Mashimo T, et al. Evidence for the involvement of GABA(A) receptor blockade in convulsions induced by cephalosporins. Neuropharmacology. 2003;45(3):304-314. (Pubitemid 36836127)
-
(2003)
Neuropharmacology
, vol.45
, Issue.3
, pp. 304-314
-
-
Sugimoto, M.1
Uchida, I.2
Mashimo, T.3
Yamazaki, S.4
Hatano, K.5
Ikeda, F.6
Mochizuki, Y.7
Terai, T.8
Matsuoka, N.9
-
22
-
-
0036887481
-
Intracerebroventricular injection of the antibiotic cefoselis produces convulsion in mice via inhibition of GABA receptors
-
Yamazaki S, Mochizuki Y, Terai T, et al. Intracerebroventricular injection of the antibiotic cefoselis produces convulsion in mice via inhibition of GABA receptors. Pharmacol Biochem Behav. 2002;74(1):53-59.
-
(2002)
Pharmacol Biochem Behav
, vol.74
, Issue.1
, pp. 53-59
-
-
Yamazaki, S.1
Mochizuki, Y.2
Terai, T.3
-
24
-
-
33645090225
-
Cefepime- and cefixime-induced encephalopathy in a patient with normal renal function
-
Capparelli FJ, Diaz MF, Hlavnika A, et al. Cefepime- and cefixime-induced encephalopathy in a patient with normal renal function. Neurology. 2005;65(11):1840.
-
(2005)
Neurology
, vol.65
, Issue.11
, pp. 1840
-
-
Capparelli, F.J.1
Diaz, M.F.2
Hlavnika, A.3
-
25
-
-
33747082964
-
Cefepime- and cefixime-induced encephalopathy in a patient with normal renal function [1]
-
DOI 10.1212/01.wnl.0000232685.01730.68, PII 0000611420060725000054
-
Fernandez-Torre JL. Cefepime- and cefixime-induced encephalopathy in a patient with normal renal function. Neurology. 2006;67(2):367. (Pubitemid 44305443)
-
(2006)
Neurology
, vol.67
, Issue.2
, pp. 367
-
-
Fernandez-Torre, J.L.1
-
26
-
-
0029867403
-
A comparison of ciprofloxacin, norfloxacin, ofloxacin, azithromycin and cefixime examined by observational cohort studies
-
Wilton LV, Pearce GL, Mann RD. A comparison of ciprofloxacin, norfloxacin, ofloxacin, azithromycin and cefixime examined by observational cohort studies. Br J Clin Pharmacol. 1996;41(4): 277-284. (Pubitemid 26114816)
-
(1996)
British Journal of Clinical Pharmacology
, vol.41
, Issue.4
, pp. 277-284
-
-
Wilton, L.V.1
Pearce, G.L.2
Mann, R.D.3
|